Name: Co-Diagnostics, Inc. (CODX) Financial Statements
Creator: FinSpry

Co-Diagnostics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Co-Diagnostics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	3.92	6.81	34.22	97.89	74.55
Cost of Revenue	1.00	4.18	5.48	11.57	16.59
Gross Profit	2.92	2.63	28.74	86.31	57.96
Operating Expenses
Research & Development	20.98	22.96	17.44	14.96	3.19
Selling, General & Administrative	20.64	21.14	21.61	24.95	29.54
Operating Expenses	43.00	45.33	-40.33	40.25	16.27
Operating Income	-40.08	-42.71	-11.59	46.06	41.69
Other Income/Expense
Interest Income	1.09	1.16	0.70	0.05	0.10
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	2.50	3.43	7.96	0.47	-0.78
Income
Income Before Tax	-37.58	-38.11	-18.85	45.64	42.57
Income Tax Expense	0.06	-2.78	-4.61	8.98	0.09
Net Income	-37.64	-35.33	-14.24	36.66	42.48
Net Income - Continuous Operations	-37.64	-35.33	-14.24	36.66	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-38.70	-41.48	-10.31	46.40	41.83
EBIT	-37.58	-42.71	-11.59	46.06	41.69
Depreciation & Amortization	1.38	1.23	1.28	0.34	0.14
Earnings Per Share
Basic EPS	-37.00	-36.00	-	38.00	2.00
Diluted EPS	-37.00	-36.00	-	37.00	2.00
Basic Shares Outstanding	1.01	0.98	31.48	0.96	26.72
Diluted Shares Outstanding	1.01	0.98	31.48	1.00	28.00